Kim Binderup

Kim Binderup has extensive work experience in the field of innovation and management. Kim currently serves as the Chief Consumer Health Officer at Vectura Fertin Pharma since 2022. Prior to this, they worked as the Vice President of Consumer- & Digital Health at Philip Morris International in 2021. Kim also held the position of Board Member at Beo Therapeutics AG from 2019 onwards.

From 2016 to 2021, Kim worked at DSM, where they held the role of Global Vice President Innovation, Human Nutrition & Health. In this role, they were responsible for leading the innovation organization, driving the innovation strategy, and managing the portfolio execution for DSM's Human Nutrition and Health business.

Before joining DSM, Kim served as a Board Member at UAS Laboratories, The Probiotic Company from 2017 to 2020. Prior to that, they worked at Chr. Hansen Holding A/S in various leadership positions, including Vice President of Innovation, Human Health, Vice President of RDA & Strategic Sourcing, Vice President of Innovation & Strategic Sourcing, Vice President of Product Development, Senior Director of Product Development, and Director of Strategic Innovation.

Kim's career began as a Management Consultant at Boston Consulting Group from 2006 to 2009. Kim then worked as a Fermentation Scientist at DSM Anti-Infectives from 2003 to 2006. Kim also held the position of Marie Curie Post Doc Fellow at Université de Lille from 2001 to 2003.

Overall, Kim Binderup has a diverse and impressive background in innovation, management, and health-related roles, with extensive experience in leading and driving innovation strategies across multiple industries.

Kim Binderup earned a PhD in Biochemistry from Michigan State University, completing the program from 1995 to 2000. Later, from 2014 to 2016, Kim attended London Business School and obtained an Executive MBA.